Autophagy in kidney transplants of sirolimus treated recipients

التفاصيل البيبلوغرافية
العنوان: Autophagy in kidney transplants of sirolimus treated recipients
المؤلفون: Jan Hegermann, Hermann Haller, Wilfried Gwinner, Roland Schmitt, Anette Melk, Matthias Ochs, Sagar Bhayana, Jan-Hinrich Bräsen, Arpita Baisantry, Clemens L. Bockmeyer, Christoph Wrede, Jan U. Becker, Thomas Kraemer
المصدر: Journal of Nephropathology
بيانات النشر: Maad Rayan Publishing Company, 2016.
سنة النشر: 2016
مصطلحات موضوعية: 0301 basic medicine, mTOR inhibitors, Cell type, Pathology, medicine.medical_specialty, 03 medical and health sciences, Autophagy, Electron microscopy, medicine, PI3K/AKT/mTOR pathway, Kidney transplantation, Sirolimus, Kidney, Kidney transplant biopsy, business.industry, Discovery and development of mTOR inhibitors, medicine.disease, 030104 developmental biology, medicine.anatomical_structure, Nephrology, Immunohistochemistry, Original Article, business, medicine.drug
الوصف: Background: Mammalian target of rapamycin (mTOR) inhibitors are increasingly used as immunosuppressive agents in kidney transplantation. In the experimental setting it has been shown that mTOR inhibitors promote autophagy, but the concept that this might also occur in transplant patients has not been addressed. Objectives: This study was designed to investigate the association between mTOR inhibition and autophagy in renal transplants under routine clinical conditions. Materials and Methods: Protocol transplant biopsies of patients receiving sirolimus were compared to biopsies of patients treated without mTOR inhibitor. Electron microscopy was used for quantitative stereological analysis of autophagosomal volume fractions. Ultrastructural analysis was focused on podocytes to avoid cell type bias. Autophagy-related gene products were profiled by QPCR from laser assisted microdissected glomeruli and by immunohistochemistry for semiquantitative evaluation. Results: By electron microscopy, we observed a significant > 50% increase in podocytic autophagosomal volume fractions in patients treated with sirolimus. Evaluation of biopsy material from the same patients using transcriptional profiling of laser capture microdissected glomeruli revealed no differences in autophagy-related gene expressions. Immunohistochemical evaluation of autophagic degradation product p62 was also unaltered whereas a significant increase was observed in podocytic LC3 positivity in biopsies of sirolimus treated patients. Conclusions: These results indicate an association of sirolimus treatment and autophagosome formation in transplant patients. However, they might reflect autophagosomal buildup rather than increased autophagic flux. Further research is needed to investigate the potential functional consequences in short- and long-term outcome of patients treated with mTOR inhibitors.
تدمد: 2251-8819
2251-8363
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade0f254f6ce4b8526013ecec146a45eTest
https://doi.org/10.15171/jnp.2017.15Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....ade0f254f6ce4b8526013ecec146a45e
قاعدة البيانات: OpenAIRE